PECAM1 and neoplasm: This inhibitory effect was ascribed to the promotion of apoptosis in tumor tissues and the restraint of proteins associated with tumor proliferation (ki67), metastasis (MMP-9), and angiogenesis (CD31 and VEGF) expression (Figure 5).